Clinical trials
Phase 1 Xerostomia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Roxane Laboratories | 2 |
| University of Wisconsin, Madison | 2 |
| Göteborg University | 1 |
| Institute of Oncology Ljubljana | 1 |
| Maastricht University Medical Center | 1 |
| MeiraGTx, LLC | 1 |
| National Institute of Dental and Craniofacial Research (NIDCR) | 1 |
| Rigshospitalet, Denmark | 1 |
| Stanford University | 1 |
| Texas A & M University Baylor College Of Dentistry | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Xerostomia | 17 |
| Head and Neck Neoplasms | 7 |
| Adenoviridae Infections | 1 |
| Dental Caries | 1 |
| Graft vs Host Disease | 1 |
| Mouth Neoplasms | 1 |
| Oropharyngeal Neoplasms | 1 |
| Pharyngeal Neoplasms | 1 |
| Salivary Gland Diseases | 1 |
| Sjogren's Syndrome | 1 |
Trials
Showing 26 to 17 of 17. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.